DGAT1 and gastric cancer: Consistently, overexpression of DGAT1 in gastric cancer tissues was identified compared to normal tissues, and gastric cancer patients with overexpression of DGAT1 (n = 109) had a lower overall survival rate (13.7%) after 50 months follow-up compared to patients with low expression of DGAT1 (n = 56, 39.3%) [147].